ACTG Protocol A5269 The Activity of Nitazoxanide in Addition to Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Treatment-Naïve Genotype 1 Subjects with HIV Coinfection

Grant

Total Award Amount

  • 56688.00
  • Direct Costs

  • 38695.00
  • Sponsor Award Id

  • CRB-APHRM-S-10-00170
  • Contributor

  • Victoria Johnson   Principal Investigator